1. Fan G, Filipczak L, Chow E. Symptom clusters in cancer patients: a review of the literature. Curr Oncol. 2007; 14:173–179. PMID:
17938700.
Article
2. Kirkova J, Walsh D, Aktas A, Davis MP. Cancer symptom clusters: old concept but new data. Am J Hosp Palliat Care. 2010; 27:282–288. PMID:
20351131.
Article
3. Jimenez A, Madero R, Alonso A, Martinez-Marin V, Vilches Y, Martinez B, et al. Symptom clusters in advanced cancer. J Pain Symptom Manage. 2011; 42:24–31. PMID:
21402468.
4. World Health Organization. Cancer pain relief: with a guide to opioids availability. Geneva: World Health Organization;1996.
5. De Lima L. International Association for Hospice and Palliative Care list of essential medicines for palliative care. Ann Oncol. 2007; 18:395–399. PMID:
17071936.
Article
6. Lindqvist O, Lundquist G, Dickman A, Bukki J, Lunder U, Hagelin CL, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med. 2013; 16:38–43. PMID:
23234300.
Article
7. Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer. 2009; 17:745–748. PMID:
19030900.
Article
8. Fede A, Miranda M, Antonangelo D, Trevizan L, Schaffhausser H, Hamermesz B, et al. Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Support Care Cancer. 2011; 19:1313–1318. PMID:
20652603.
Article
9. Bayliss EA, Bronsert MR, Reifler LM, Ellis JL, Steiner JF, McQuillen DB, et al. Statin prescribing patterns in a cohort of cancer patients with poor prognosis. J Palliat Med. 2013; 16:412–418. PMID:
23305190.
Article
10. Pud D, Ben Ami S, Cooper BA, Aouizerat BE, Cohen D, Radiano R, et al. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage. 2008; 35:162–170. PMID:
18082357.
Article
11. Teunissen SC, de Graeff A, de Haes HC, Voest EE. Prognostic significance of symptoms of hospitalised advanced cancer patients. Eur J Cancer. 2006; 42:2510–2516. PMID:
16962316.
Article
12. Narducci F, Grande R, Mentuccia L, Trapasso T, Sperduti I, Magnolfi E, et al. Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study. Support Care Cancer. 2012; 20:1221–1226. PMID:
21688165.
Article
13. Curtis EB, Walsh TD. Prescribing practices of a palliative care service. J Pain Symptom Manage. 1993; 8:312–316. PMID:
7525747.
Article
14. Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer. 2007; 15:1407–1412. PMID:
17429699.
Article
15. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007; 55:590–595. PMID:
17397439.
Article
16. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990; 6:7–15. PMID:
1704917.
Article
17. Sim YS, Kim DY, Nam EM, Lee SM. Symptom experience in terminal cancer patients during the last 48 hours of life. Korean J Hosp Palliat Care. 2007; 10:190–194.
18. Koh SJ, Lee KS, Hong YS, Yoo YS, Park HJ. Clinical change of terminally ill cancer patients at the end-of-life time. Korean J Hosp Palliat Care. 2008; 11:99–105.
19. Radha Krishna LK, Poulose VJ, Goh C. The use of midazolam and haloperidol in cancer patients at the end of life. Singapore Med J. 2012; 53:62–66. PMID:
22252186.
20. Jecker NS, Pearlman RA. Medical futility. Who decides? Arch Intern Med. 1992; 152:1140–1144. PMID:
1599340.
Article
21. Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med. 2005; 8:876–881. PMID:
16128666.
Article